Emerging Biopharma

China
Biotech

GSK, Merck and Pfizer in Ab&B's sights as biotech files for IPO

Ab&B filed for an IPO to fund development of vaccines that could compete with shots from companies including GSK, Merck & Co. and Pfizer.
Nick Paul Taylor Jan 23, 2025 8:01am
sickle cell blood anemia

Novo inks IMMvention deal to orchestrate attack on sickle cell

Jan 22, 2025 9:41am
IPO initial public offering

BMS, Takeda's Chinese partners file for IPOs

Jan 22, 2025 6:11am
eye eyeball eye art

Sling's oral Tepezza rival hits goal in thyroid eye disease

Jan 14, 2025 8:16am
weight loss scale weigh measure tape obesity overweight

Kailera reports Zepbound-rivaling weight loss in obesity phase 2

Jan 13, 2025 10:20am
money cash coins dollars

Mountainfield, China's Keymed launch biotech with $180M series A

Jan 10, 2025 8:43am
More News

Eli Lilly to pay Mediar $99M for pulmonary fibrosis prospect

Jan 10, 2025 8:35am

Verdiva launches with $410M, weekly-dosed oral GLP-1 candidate

Jan 9, 2025 2:00am

Tenvie takes off with $200M, assets and exec from Denali

Jan 8, 2025 8:00am

LB Pharma's twist on old Sanofi drug passes schizophrenia test

Jan 8, 2025 7:00am